Institute of Social Medicine, Occupational Health and Public Health, Leipzig University, Leipzig, Sachsen, Germany
Institute of Social Medicine, Occupational Health and Public Health, Leipzig University, Leipzig, Sachsen, Germany.
BMJ Open. 2023 Jun 20;13(6):e067930. doi: 10.1136/bmjopen-2022-067930.
Internet-based and mobile-based interventions (IMIs) provide innovative low-threshold and cost-effective prevention and self-management options for mental health problems complementary to standard treatment. The objective of this systematic review is to summarise the effectiveness and to critically evaluate studies on IMIs addressing comorbid depressive symptoms in adults with overweight or obesity.
The study authors will systematically search the databases MEDLINE, Cochrane Library, PsycINFO, Web of Science, Embase and Google Scholar (for grey literature) for randomised controlled trials (RCTs) of IMIs for individuals with overweight or obesity and comorbid depressive symptoms without restrictions on publication date (planned inception 1 June 2023 to 1 December 2023). Two reviewers will independently extract and evaluate data from studies eligible for inclusion by assessing quality of evidence and qualitatively synthesising results. Preferred Reporting Items for Systematic reviews Meta-Analyses (PRISMA) standards and the revised Cochrane Risk of Bias tool in RCTs (RoB 2) will be applied.
Ethical approval is not required as no primary data will be collected. Study results will be disseminated through publication in a peer-reviewed journal and presentations on conferences.
CRD42023361771.
基于互联网和移动的干预措施（IMIs）为心理健康问题的预防和自我管理提供了创新的、低门槛和具有成本效益的选择，补充了标准治疗。本系统评价的目的是总结针对超重或肥胖成年人共病抑郁症状的 IMIs 的有效性，并对相关研究进行批判性评估。
研究作者将系统地搜索 MEDLINE、Cochrane 图书馆、PsycINFO、Web of Science、Embase 和 Google Scholar（用于灰色文献）中的随机对照试验（RCTs），这些 RCT 针对超重或肥胖且共病抑郁症状的个体，不限制发表日期（计划于 2023 年 6 月 1 日至 2023 年 12 月 1 日开始）。两名评审员将通过评估证据质量并定性综合结果，独立地从符合纳入标准的研究中提取和评估数据。将应用系统评价的首选报告项目（PRISMA）标准和 RCT 中修订的 Cochrane 偏倚风险工具（RoB 2）。
由于不收集原始数据，因此不需要伦理批准。研究结果将通过在同行评议的期刊上发表和在会议上展示来传播。
PROSPERO 注册号：CRD42023361771。
